Chris Brightling
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Professor Chris Brightling or Christopher Brightling is a British doctor and researcher specialising in respiratory conditions in Leicester, UK.[1][2][3] Chris Brightling's research focuses on the role of the immune system in asthma, chronic cough and COPD.
Long COVID[edit | edit source]
Chris Brightling is chief investigator for the PHOSP-COVID study, a post-hospitalisation COVID-19 study which aims to investigate long-term outcomes of patients with severe COVID-19, and may run for up to 25 years.[4]
Talks and interviews[edit | edit source]
Notable studies and publications[edit | edit source]
- 2020, Guidance production before evidence generation for critical issues: the example of COVID-19[5] - (Full text)
- 2020, Proning reduces ventilation heterogeneity in patients with elevated BMI: implications for COVID-19 pneumonia management?[6] - (Full text)
Online presence[edit | edit source]
- PubMed
- Researchgate profile
- Website
- YouTube
See also[edit | edit source]
Learn more[edit | edit source]
- COVID-19 DISCOVER study - North Bristol NHS Trust
- PHOSP-COVID study - Leicester BRC
References[edit | edit source]
- ↑ University of Leicester. "Professor Chris Brightling". University of Leicester. Retrieved October 10, 2020.
- ↑ National Health Service. "Christopher Brightling - Consultant Profile". National Health Service. Retrieved October 10, 2020.
- ↑ "PHOSP-COVID study". leicesterbrc.nihr.ac.uk. Retrieved October 10, 2020.
- ↑ Roche, Nicolas; Tonia, Thomy; Bush, Andrew; Brightling, Chris; Kolb, Martin; Dinh-Xuan, Anh Tuan; Humbert, Marc; Simonds, Anita; Adir, Yochai (September 30, 2020). "Guidance production before evidence generation for critical issues: the example of COVID-19". European Respiratory Review. 29 (157). doi:10.1183/16000617.0310-2020. ISSN 0905-9180. PMID 33020070.
- ↑ Foy, Brody H.; Brightling, Christopher E.; Siddiqui, Salman (April 1, 2020). "Proning reduces ventilation heterogeneity in patients with elevated BMI: implications for COVID-19 pneumonia management?". ERJ Open Research. 6 (2). doi:10.1183/23120541.00292-2020. ISSN 2312-0541.
